Niklas Palmqvist, PhD

Niklas Palmqvist, PhD, has extensive experience in the field of biopharma. Niklas has worked as a Senior Scientist at Hansa Biopharma AB (publ) since April 2018. Prior to that, they held the same role at Anamar AB from September 2005 to July 2016. At Anamar AB, their work involved drug projects in various stages of development, with a focus on inflammation-related indications such as rheumatoid arthritis, atopic dermatitis, diabetic ulcers, NASH/liver fibrosis, and osteoarthritis.

Niklas Palmqvist, PhD, obtained their MSc in Pharmaceutical Bioscience from the University of Gothenburg in 2000. Niklas then pursued further education and completed their PhD in the field of Rheumatology and Inflammation Research from the same institution in 2004.